Chronic Migraine in Children research hub

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

This study is testing a new medicine, eptinezumab, for young people aged 12 to 17 who get chronic migraines. It wants to see if this medicine can reduce the number of migraine days compared to a dummy treatment.